– USA, CA – Atara Biotherapeutics, Inc. (Nasdaq: ATRA) today announced the appointment of Carol Gallagher as Chair of the Board of Directors, replacing Ron Renaud, who is stepping down from the Board.
Atara also announced that Dr. Roy Baynes will step down from the Board of Directors.
About Carol Gallagher
Carol Gallagher, Pharm.D. is a venture partner in the life sciences practice of New Enterprise Associates and an experienced public company director. She has served as a Director at Atara since 2013 and as a member of both the Compensation and Nominating and Corporate Governance Committees. Gallagher was formerly the President and CEO of Calistoga Pharmaceuticals and has held commercial and drug development roles within Eli Lilly, Amgen, Agouron, Pfizer, and Biogen Idec.
About Atara Biotherapeutics, Inc.
Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with severe diseases including solid tumors, hematologic cancers, and autoimmune diseases. With our lead program receiving marketing authorization in Europe, Atara is the most advanced allogeneic T-cell immunotherapy company. It intends to rapidly deliver off-the-shelf treatments to patients with high unmet medical needs. Our platform leverages the unique biology of EBV T cells and can treat a wide range of EBV-associated diseases or other serious diseases through the incorporation of engineered CARs (chimeric antigen receptors) or TCRs (T-cell receptors). Atara is applying this one platform, which does not require TCR or HLA gene editing, to create a robust pipeline including tab-cel for Epstein-Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD) and other EBV-driven diseases; ATA188, T-cell immunotherapy targeting EBV antigens as a potential treatment for multiple sclerosis; and multiple next-generation chimeric antigen receptor T-cell (CAR-T) immunotherapies for both solid tumors and hematologic malignancies. Improving patients’ lives is our mission and we will never stop working to bring transformative therapies to those in need. Atara is headquartered in Southern California.
For more information: https://www.atarabio.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.